Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Rowinsky

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Annals of Internal Medicine|August 15, 1989
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasmsW P McGuire, E K Rowinsky, N B Rosenshein, et al.
Cancer|April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II studyW John, J Picus, C D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumorsA W Tolcher, C Aylesworth, J Rizzo, et al.
Journal of the National Cancer Institute|October 21, 1999
Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesotheliomaP M Fracasso, B R Tan, M Grieff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
The effects of food and divided dosing on the bioavailability of oral vinorelbineE K Rowinsky, V S Lucas, A L Hsieh, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Annals of Internal Medicine|August 15, 1989
Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasmsW P McGuire, E K Rowinsky, N B Rosenshein, et al.
Cancer|April 13, 2000
Activity of multitargeted antifolate (pemetrexed disodium, LY231514) in patients with advanced colorectal carcinoma: results from a phase II studyW John, J Picus, C D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony-stimulating factor in women with previously treated metastatic breast cancerM J Kennedy, M L Zahurak, R C Donehower, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumorsA W Tolcher, C Aylesworth, J Rizzo, et al.
Journal of the National Cancer Institute|October 21, 1999
Membranoproliferative glomerulonephritis following gemcitabine and vinorelbine chemotherapy for peritoneal mesotheliomaP M Fracasso, B R Tan, M Grieff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumorsS O'Reilly, L B Grochow, R C Donehower, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Oral paclitaxel and concurrent cyclosporin A: targeting clinically relevant systemic exposure to paclitaxelC D Britten, S D Baker, L J Denis, et al.
Journal of the National Cancer Institute|December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexateA Hantel, E K Rowinsky, D A Noe, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
The effects of food and divided dosing on the bioavailability of oral vinorelbineE K Rowinsky, V S Lucas, A L Hsieh, et al.
Pageof 16